| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16714-815-01 | 16714-815 | HUMAN PRESCRIPTION DRUG | Zoledronic acid | zoledronic acid | INJECTION | INTRAVENOUS | 20180530 | 20250831 | ANDA | ANDA205279 | Northstar RxLLC | ZOLEDRONIC ACID | 4 mg/5mL | 1 VIAL in 1 CARTON (16714-815-01) / 5 mL in 1 VIAL |
| 16729-242-31 | 16729-242 | HUMAN PRESCRIPTION DRUG | Zoledronic acid | zoledronic acid | INJECTION | INTRAVENOUS | 20171016 | N/A | ANDA | ANDA205279 | Accord Healthcare Inc. | ZOLEDRONIC ACID | 4 mg/5mL | 1 VIAL in 1 CARTON (16729-242-31) / 5 mL in 1 VIAL |
| 68001-437-25 | 68001-437 | HUMAN PRESCRIPTION DRUG | Zoledronic acid | zoledronic acid | INJECTION | INTRAVENOUS | 20200629 | N/A | ANDA | ANDA205279 | BluePoint Laboratories | ZOLEDRONIC ACID | 4 mg/5mL | 1 VIAL in 1 CARTON (68001-437-25) / 5 mL in 1 VIAL |